Sodium 2-mercapto ethane sulfonate is used as a protective agent in:
**Core Concept**
Sodium 2-mercapto ethane sulfonate, also known as mesna, is an antidote and protective agent used to prevent hemorrhagic cystitis caused by certain chemotherapeutic agents, particularly ifosfamide and cyclophosphamide. It acts by conjugating with acrolein, a toxic metabolite of these drugs, thereby reducing its toxic effects.
**Why the Correct Answer is Right**
Mesna works by forming a stable conjugate with acrolein, which is the primary toxic metabolite responsible for hemorrhagic cystitis. This conjugation reaction occurs through a nucleophilic addition mechanism, where the sulfhydryl group of mesna reacts with the alpha, beta-unsaturated aldehyde of acrolein, resulting in the formation of a stable, non-toxic adduct. This prevents acrolein from causing damage to the bladder mucosa, thereby reducing the risk of hemorrhagic cystitis.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to the use of sodium 2-mercapto ethane sulfonate.
**Option B:** This option is incorrect as mesna is not primarily used for this purpose.
**Option C:** This option is incorrect as mesna is not used as a protective agent for this condition.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that mesna is specifically used to prevent hemorrhagic cystitis caused by ifosfamide and cyclophosphamide, and its administration is usually initiated 24 hours before chemotherapy and continued for 2-3 days after treatment.
**Correct Answer:** C.